Statistics
Total Visits
| Views | |
|---|---|
| Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial | 108 |
Total Visits per Month
| June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | |
|---|---|---|---|---|---|---|---|
| Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial | 7 | 6 | 1 | 10 | 3 | 3 | 6 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 69 |
| Germany | 9 |
| China | 7 |
| Australia | 5 |
| Russia | 3 |
| Argentina | 2 |
| Belgium | 2 |
| Czechia | 2 |
| United Kingdom | 2 |
| India | 2 |
Top City Views
| Views | |
|---|---|
| Ashburn | 16 |
| Fairfield | 9 |
| San Diego | 6 |
| Ann Arbor | 4 |
| Des Moines | 4 |
| Dearborn | 3 |
| Portland | 3 |
| Sacramento | 2 |
| Shenzhen | 2 |
| Suipacha | 2 |